University of Opole Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2021
NCT04705337
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

The Opole University of Technology | University of Opole | University of Opole, Poland

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Atrial Fibrillation (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 8